Note*: This report requires 7-10 business days to complete.
DelveInsight’s Eczema - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Eczema forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Eczema till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Eczema market.
• Identifying patient populations in the global “Eczemamarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Eczema therapeutics in each of the markets covered.
• To understand the future market competition in the global Eczema therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Eczema for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Eczema overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Eczema Market
• Global Epidemiology of Eczema Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Eczema Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Eczema (2013-2023)
• Table 7: Eczema Global Market (USD Millions), (2013-2015)
• Table 8: Eczema Global Market (USD Millions), (2016-2023)
• Table 9: Eczema US Market (USD Millions), (2013-2015)
• Table 10: Eczema US Market (USD Millions), (2016-2023)
• Table 11: Eczema Germany Market (USD Millions), (2013-2015)
• Table 12: Eczema Germany Market (USD Millions), (2016-2023)
• Table 13: Eczema United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Eczema United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Eczema France Market (USD Millions), (2013-2015)
• Table 16: Eczema France Market (USD Millions), (2016-2023)
• Table 17: Eczema Italy Market (USD Millions), (2013-2015)
• Table 18: Eczema Italy Market (USD Millions), (2016-2023)
• Table 19: Eczema Spain Market (USD Millions), (2013-2015)
• Table 20: Eczema Spain Market (USD Millions), (2016-2023)
• Table 21: Eczema Japan Market (USD Millions), (2013-2015)
• Table 22: Eczema Japan Market (USD Millions), (2016-2023)
• Table 23: Eczema ROW Market (USD Millions), (2013-2015)
• Table 24: Eczema ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Eczema Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Eczema (2013-2023)
• Figure 3: Eczema Global Market (USD Millions), (2013-2015)
• Figure 4: Eczema Global Market (USD Millions), (2016-2023)
• Figure 5: Eczema US Market (USD Millions), (2013-2015)
• Figure 6: Eczema US Market (USD Millions), (2016-2023)
• Figure 7: Eczema Germany Market (USD Millions), (2013-2015)
• Figure 8: Eczema Germany Market (USD Millions), (2016-2023)
• Figure 9: Eczema United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Eczema United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Eczema France Market (USD Millions), (2013-2015)
• Figure 12: Eczema France Market (USD Millions), (2016-2023)
• Figure 13: Eczema Italy Market (USD Millions), (2013-2015)
• Figure 14: Eczema Italy Market (USD Millions), (2016-2023)
• Figure 15: Eczema Spain Market (USD Millions), (2013-2015)
• Figure 16: Eczema Spain Market (USD Millions), (2016-2023)
• Figure 17: Eczema Japan Market (USD Millions), (2013-2015)
• Figure 18: Eczema Japan Market (USD Millions), (2015-2023)
• Figure 19: Eczema ROW Market (USD Millions), (2013-2015)
• Figure 20: Eczema ROW Market (USD Millions), (2016-2023)
• Novartis AG
• GlaxoSmithKline Plc
• Astellas Pharma Inc.
• Sanofi
• Regeneron Pharmaceuticals Inc.
• The LEO Foundation
• Bayer AG
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Anacor Pharmaceuticals Inc.
